RESMED INC — Director's Dealing 2016

Jun 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-06-15

Reporting Person: Hollingshead James (President, Americas)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-15	ResMed Common Stock	S	4458	$59.4049	Disposed	43422	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 Plan.

F2: This transaction was executed in multiple trades at prices ranging from $59.15 to $59.72. The price reported above reflects the weighted average sale price.

F3: Includes 310.816 shares of ResMed stock purchased on 5/5/2016, through the ResMed Employee Stock Purchase Plan.